- Home
- DYN vs ADEA Comparison
DYN vs ADEA Comparison
Compare DYN & ADEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- ADEA
- Stock Information
- Founded
- DYN 1984
- ADEA 1990
- Country
- DYN United States
- ADEA United States
- Employees
- DYN N/A
- ADEA N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- ADEA Computer Software: Prepackaged Software
- Sector
- DYN Health Care
- ADEA Technology
- Exchange
- DYN Nasdaq
- ADEA Nasdaq
- Market Cap
- DYN 1.9B
- ADEA 1.6B
- IPO Year
- DYN 2020
- ADEA N/A
- Fundamental
- Price
- DYN $14.22
- ADEA $15.43
- Analyst Decision
- DYN Strong Buy
- ADEA Strong Buy
- Analyst Count
- DYN 14
- ADEA 4
- Target Price
- DYN $34.93
- ADEA $19.50
- AVG Volume (30 Days)
- DYN 2.4M
- ADEA 486.2K
- Earning Date
- DYN 07-28-2025
- ADEA 08-05-2025
- Dividend Yield
- DYN N/A
- ADEA 1.30%
- EPS Growth
- DYN N/A
- ADEA 80.44
- EPS
- DYN N/A
- ADEA 0.74
- Revenue
- DYN N/A
- ADEA $378,674,000.00
- Revenue This Year
- DYN N/A
- ADEA $9.49
- Revenue Next Year
- DYN N/A
- ADEA $4.94
- P/E Ratio
- DYN N/A
- ADEA $20.83
- Revenue Growth
- DYN N/A
- ADEA 5.47
- 52 Week Low
- DYN $6.36
- ADEA $10.59
- 52 Week High
- DYN $37.08
- ADEA $17.46
- Technical
- Relative Strength Index (RSI)
- DYN 73.48
- ADEA 60.35
- Support Level
- DYN $13.03
- ADEA $15.28
- Resistance Level
- DYN $13.85
- ADEA $15.73
- Average True Range (ATR)
- DYN 0.64
- ADEA 0.48
- MACD
- DYN 0.04
- ADEA -0.00
- Stochastic Oscillator
- DYN 95.55
- ADEA 75.00
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, the company licenses innovations to companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.